FOCAL CORTICAL DYSPLASIA

Clinical trials for FOCAL CORTICAL DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new FOCAL CORTICAL DYSPLASIA trials appear

Sign up with your email to follow new studies for FOCAL CORTICAL DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New pill aims to tame seizures in rare brain disorders

Disease control Not yet recruiting

This early-stage trial tests an oral drug called SVG103 (Paxalisib) in 15 adults with rare brain conditions (FCD-II, TSC, or HME) that cause seizures. The main goal is to check safety and side effects, while also seeing if it reduces seizure frequency. Participants take the drug …

Matched conditions: FOCAL CORTICAL DYSPLASIA

Phase: PHASE1, PHASE2 • Sponsor: Sovargen • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC

FOCAL CORTICAL DYSPLASIA

Get alerted when new FOCAL CORTICAL DYSPLASIA trials appear

New pill aims to tame seizures in rare brain disorders